Literature DB >> 20109729

Recent insights into atopic dermatitis and implications for management of infectious complications.

Mark Boguniewicz1, Donald Y M Leung.   

Abstract

Atopic dermatitis (AD) is a common complex disease that frequently follows a chronic relapsing course and affects the quality of life of patients and families in a significant manner. New insights into the pathophysiology of AD point to an important role of structural abnormalities in the epidermis combined with immune dysregulation. Patients with AD have a unique predisposition to colonization or infection by a number of microbial organisms, most notably Staphylococcus aureus and herpes simplex virus. A multipronged approach directed at healing or protecting the skin barrier and addressing the immune dysregulation is necessary to improve the likelihood of successful outcomes. Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20109729      PMCID: PMC2814072          DOI: 10.1016/j.jaci.2009.11.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  116 in total

Review 1.  Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Authors:  Cezmi A Akdis; Mübeccel Akdis; Thomas Bieber; Carsten Bindslev-Jensen; Mark Boguniewicz; Philippe Eigenmann; Qutayba Hamid; Alexander Kapp; Donald Y M Leung; Jasna Lipozencic; Thomas A Luger; Antonella Muraro; Natalija Novak; Thomas A E Platts-Mills; Lanny Rosenwasser; Annika Scheynius; F Estelle R Simons; Jonathan Spergel; Kristiina Turjanmaa; Ulrich Wahn; Stefan Weidinger; Thomas Werfel; Torsten Zuberbier
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

2.  Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics.

Authors:  Shuo-Hsun Hung; Yu-Tsan Lin; Chia-Yu Chu; Chien-Chang Lee; Tien-Chi Liang; Yao-Hsu Yang; Li-Chieh Wang; Bor-Luen Chiang
Journal:  Ann Allergy Asthma Immunol       Date:  2007-01       Impact factor: 6.347

Review 3.  The socioeconomic impact of atopic dermatitis in the United States: a systematic review.

Authors:  Anthony J Mancini; Kellee Kaulback; Sarah L Chamlin
Journal:  Pediatr Dermatol       Date:  2008 Jan-Feb       Impact factor: 1.588

4.  Correlation of IL-31 serum levels with severity of atopic dermatitis.

Authors:  Ulrike Raap; Katja Wichmann; Manuela Bruder; Sonja Ständer; Bettina Wedi; Alexander Kapp; Thomas Werfel
Journal:  J Allergy Clin Immunol       Date:  2008-08       Impact factor: 10.793

Review 5.  A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.

Authors:  S Jolles
Journal:  Clin Exp Dermatol       Date:  2002-01       Impact factor: 3.470

6.  Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation.

Authors:  Michael D Howell; Heather R Fairchild; Byung Eui Kim; Lianghua Bin; Mark Boguniewicz; Jasmina S Redzic; Kirk C Hansen; Donald Y M Leung
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

7.  Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis.

Authors:  Joohee Lee; David Seto; Leonard Bielory
Journal:  J Allergy Clin Immunol       Date:  2008-01       Impact factor: 10.793

8.  Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.

Authors:  A Peserico; G Städtler; M Sebastian; R Suarez Fernandez; K Vick; T Bieber
Journal:  Br J Dermatol       Date:  2008-02-16       Impact factor: 9.302

9.  Infection control by antibody disruption of bacterial quorum sensing signaling.

Authors:  Junguk Park; Reshma Jagasia; Gunnar F Kaufmann; John C Mathison; Diana I Ruiz; Jason A Moss; Michael M Meijler; Richard J Ulevitch; Kim D Janda
Journal:  Chem Biol       Date:  2007-10

10.  Antiviral activity of human beta-defensin 3 against vaccinia virus.

Authors:  Michael D Howell; Joanne E Streib; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2007-03-13       Impact factor: 10.793

View more
  91 in total

Review 1.  Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.

Authors:  Jocelyn M Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

2.  Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.

Authors:  Eric B Brandt; Aaron M Gibson; Stacey Bass; Carolyn Rydyznski; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.

Authors:  Joanne Domenico; Joseph J Lucas; Mayumi Fujita; Erwin W Gelfand
Journal:  Int Arch Allergy Immunol       Date:  2012-01-26       Impact factor: 2.749

4.  Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization.

Authors:  Adrian Chan; William Terry; Hongmei Zhang; Wilfried Karmaus; Susan Ewart; John W Holloway; Graham Roberts; Ramesh Kurukulaaratchy; Syed Hasan Arshad
Journal:  Clin Exp Allergy       Date:  2018-02       Impact factor: 5.018

5.  Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.

Authors:  Hitokazu Esaki; David A Ewald; Benjamin Ungar; Mariya Rozenblit; Xiuzhong Zheng; Hui Xu; Yeriel D Estrada; Xiangyu Peng; Hiroshi Mitsui; Thomas Litman; Mayte Suárez-Fariñas; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-01       Impact factor: 10.793

6.  Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.

Authors:  Anna De Benedetto; Mark K Slifka; Nicholas M Rafaels; I-Hsin Kuo; Steve N Georas; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon M Hanifin; Richard L Gallo; David C Johnson; Kathleen C Barnes; Donald Y M Leung; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2011-04-13       Impact factor: 10.793

7.  Transplantation of human skin microbiota in models of atopic dermatitis.

Authors:  Ian A Myles; Kelli W Williams; Jensen D Reckhow; Momodou L Jammeh; Nathan B Pincus; Inka Sastalla; Danial Saleem; Kelly D Stone; Sandip K Datta
Journal:  JCI Insight       Date:  2016-07-07

8.  First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.

Authors:  Ian A Myles; Noah J Earland; Erik D Anderson; Ian N Moore; Mark D Kieh; Kelli W Williams; Arhum Saleem; Natalia M Fontecilla; Pamela A Welch; Dirk A Darnell; Lisa A Barnhart; Ashleigh A Sun; Gulbu Uzel; Sandip K Datta
Journal:  JCI Insight       Date:  2018-05-03

9.  High-intensity swimming exercise increases dust mite extract and 1-chloro-2,4-dinitrobenzene-derived atopic dermatitis in BALB/c mice.

Authors:  Sang-Hyun Kim; Eun-Kyung Kim; Eun-Ju Choi
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

10.  Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population.

Authors:  Tomomitsu Hirota; Atsushi Takahashi; Michiaki Kubo; Tatsuhiko Tsunoda; Kaori Tomita; Masafumi Sakashita; Takechiyo Yamada; Shigeharu Fujieda; Shota Tanaka; Satoru Doi; Akihiko Miyatake; Tadao Enomoto; Chiharu Nishiyama; Nobuhiro Nakano; Keiko Maeda; Ko Okumura; Hideoki Ogawa; Shigaku Ikeda; Emiko Noguchi; Tohru Sakamoto; Nobuyuki Hizawa; Koji Ebe; Hidehisa Saeki; Takashi Sasaki; Tamotsu Ebihara; Masayuki Amagai; Satoshi Takeuchi; Masutaka Furue; Yusuke Nakamura; Mayumi Tamari
Journal:  Nat Genet       Date:  2012-10-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.